首页> 外文期刊>International Journal of Pharmaceutical Sciences and Research >DRUG UTILISATION PATTERN OF PSYCHOTROPIC DRUGS IN PSYCHIATRIC OUTPATIENT DEPARTMENT OF RURAL TERTIARY CARE TEACHING HOSPITAL
【24h】

DRUG UTILISATION PATTERN OF PSYCHOTROPIC DRUGS IN PSYCHIATRIC OUTPATIENT DEPARTMENT OF RURAL TERTIARY CARE TEACHING HOSPITAL

机译:乡镇医院精神科门诊部精神病药物的药物利用模式。

获取原文
           

摘要

Background: Psychiatric disorders are one of the major causes of morbidity. Development of newer drugs like selective serotonin reuptake inhibitors and atypical antipsychotics has altered the treatment paradigms. Objective : To study drug utilization pattern of psychotropic drugs in psychiatric outpatient department. Material and Methods: After ethical approval six month observational, prospective study was conducted at tertiary care hospital, South India. Prescriptions containing at least one psychotropic drugs were included. Data was measured for number and percentage of prescriptions or drugs and using selected World Health Organization (WHO) drug use indicators. Microsoft excel was used to summarize and graph pad instat was used for analysis of data as appropriate.(P < 0.05). Results: 101 prescription contained 187drugs (1.851±0.8 per prescription) where 67.33% of prescriptions had more than 2 psychotropic drugs introducing psychiatric polypharmacy. Selected WHO drug use indicators showed some potential problems in prescriptions which can be improved. Antidepressants (41.49%) were prescribed more followed by sedative/hypnotics (34.69%), antipsychotics (16.3%) and antimaniac drugs (7.4%). Among antidepressants, Sertraline was highly prescribed followed by Amitriptyline, Escitalopram and Mirtazepine. Clonazepam was frequently prescribed sedative/hypnotic. All antipsychotics were newer generation adjuncted with central anticholinergics; Risperidone being first choice. For mania, Valproic acid was frequently used. Among these drugs; frequently Clonazepam (24.48%) and infrequently Quetiapine (1.36%) were used. Conclusion: The trend of prescribing in psychiatry is shifted to newer drugs like selective serotonin reuptake inhibitors and atypical antipsychotics. There is evidence of practice of psychiatric polypharmacy. Results of WHO drug use indicators also showed need to improve prescribing habits to ensure rational use
机译:背景:精神疾病是发病的主要原因之一。选择性5-羟色胺再摄取抑制剂和非典型抗精神病药等新药的开发改变了治疗范式。目的:研究精神科门诊精神药物的用药模式。材料和方法:经伦理学批准六个月的观察后,在南印度的三级医院进行了前瞻性研究。包括至少一种精神药物的处方。使用选定的世界卫生组织(WHO)药物使用指标对数据进行了处方或药物数量和百分比的测量。使用Microsoft excel进行总结,并使用pad pad instat进行数据分析(P <0.05)。结果:101个处方中包含187种药物(每个处方1.851±0.8个),其中67.33%的处方中有2种以上的精神药物引入了精神科综合药房。选定的WHO药物使用指标显示处方中存在一些潜在问题,可以改进。开了更多的抗抑郁药(41.49%),其次是镇静/催眠药(34.69%),抗精神病药(16.3%)和抗躁狂药(7.4%)。在抗抑郁药中,强烈建议使用舍曲林,然后是阿米替林,艾司西酞普兰和米氮平。经常给氯硝西am镇静/催眠药。所有的抗精神病药都是新一代的中枢性抗胆碱能药。利培酮是首选。对于躁狂症,经常使用丙戊酸。在这些药物中;经常使用氯硝西am(24.48%)和很少使用喹硫平(1.36%)。结论:精神病学开处方的趋势已转向新型药物,如选择性5-羟色胺再摄取抑制剂和非典型抗精神病药。有实践证明精神科多药房。世卫组织药物使用指标的结果还表明,需要改善处方习惯,以确保合理使用

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号